M. P. Glauser

1.7k total citations
33 papers, 1.3k citations indexed

About

M. P. Glauser is a scholar working on Epidemiology, Immunology and Pharmacology. According to data from OpenAlex, M. P. Glauser has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in M. P. Glauser's work include Immune Response and Inflammation (10 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Resistance in Bacteria (5 papers). M. P. Glauser is often cited by papers focused on Immune Response and Inflammation (10 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Resistance in Bacteria (5 papers). M. P. Glauser collaborates with scholars based in Switzerland, United Kingdom and United States. M. P. Glauser's co-authors include Didier Heumann, J. D. Baumgartner, C Barras, Philippe Gallay, Christophe Büla, Peter S. Tobias, Gláucia Zanetti, J. Cohen, Didier Le Roy and Richard J. Ulevitch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Immunology.

In The Last Decade

M. P. Glauser

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. P. Glauser Switzerland 18 618 384 208 166 163 33 1.3k
M T van den Barselaar Netherlands 20 642 1.0× 230 0.6× 325 1.6× 43 0.3× 85 0.5× 35 1.4k
Eliza B. Wolfson United Kingdom 11 708 1.1× 235 0.6× 333 1.6× 40 0.2× 54 0.3× 12 1.3k
Fernando G. Chirdo Argentina 27 559 0.9× 535 1.4× 382 1.8× 83 0.5× 164 1.0× 72 2.1k
François Parant France 18 551 0.9× 240 0.6× 361 1.7× 44 0.3× 51 0.3× 76 1.4k
Christian Draing Germany 19 653 1.1× 284 0.7× 348 1.7× 21 0.1× 231 1.4× 26 1.5k
L. Amati Italy 18 318 0.5× 245 0.6× 331 1.6× 37 0.2× 193 1.2× 44 1.3k
James K. Roche United States 30 475 0.8× 392 1.0× 424 2.0× 46 0.3× 60 0.4× 64 2.2k
Donald A. Ferguson United States 22 579 0.9× 361 0.9× 287 1.4× 18 0.1× 63 0.4× 44 1.6k
David P. Funda Czechia 18 435 0.7× 238 0.6× 506 2.4× 28 0.2× 151 0.9× 42 1.6k
Line Larivière Canada 9 1.4k 2.2× 272 0.7× 306 1.5× 21 0.1× 83 0.5× 10 1.7k

Countries citing papers authored by M. P. Glauser

Since Specialization
Citations

This map shows the geographic impact of M. P. Glauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. Glauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. Glauser more than expected).

Fields of papers citing papers by M. P. Glauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. Glauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. Glauser. The network helps show where M. P. Glauser may publish in the future.

Co-authorship network of co-authors of M. P. Glauser

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. Glauser. A scholar is included among the top collaborators of M. P. Glauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. Glauser. M. P. Glauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baughman, Robert P. & M. P. Glauser. (2005). Managing serious infections in the hospital: a new model. Clinical Microbiology and Infection. 11. 1–3. 1 indexed citations
2.
Phillips, Andrew, Adriano Lazzarin, Nathan Clumeck, et al.. (1996). Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. Journal of Clinical Epidemiology. 49(11). 1253–1258. 10 indexed citations
3.
4.
Heumann, Didier, S. Bas, Philippe Gallay, et al.. (1995). Lipopolysaccharide binding protein as a marker of inflammation in synovial fluid of patients with arthritis: correlation with interleukin 6 and C-reactive protein.. PubMed. 22(7). 1224–9. 29 indexed citations
5.
Büla, Christophe, et al.. (1995). An Epidemic of Food-Borne Listeriosis in Western Switzerland: Description of 57 Cases Involving Adults. Clinical Infectious Diseases. 20(1). 66–72. 174 indexed citations
6.
Gallay, Philippe, C Barras, Peter S. Tobias, et al.. (1994). Lipopolysaccharide (LPS)-Binding Protein In Human Serum Determines The Tumor Necrosis Factor Response Of Monocytes To LPS. The Journal of Infectious Diseases. 170(5). 1319–1322. 58 indexed citations
7.
Cometta, Alain, J. D. Baumgartner, & M. P. Glauser. (1994). Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients.. PubMed. 97 Suppl 1. 69–72. 18 indexed citations
8.
Heumann, Didier, et al.. (1993). IFN-gamma involvement in the severity of gram-negative infections in mice.. The Journal of Immunology. 151(2). 916–921. 88 indexed citations
9.
Zanetti, Gláucia, Didier Heumann, J. Gérain, et al.. (1992). Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. The Journal of Immunology. 148(6). 1890–1897. 200 indexed citations
10.
Baumgartner, J. D., Didier Heumann, Thierry Calandra, & M. P. Glauser. (1991). Antibodies to Lipopolysaccharides after Immunization of Humans with the Rough Mutant Escherichia coli J5. The Journal of Infectious Diseases. 163(4). 769–772. 40 indexed citations
11.
Heumann, Didier, et al.. (1991). Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides. The Journal of Infectious Diseases. 163(4). 762–768. 42 indexed citations
12.
Glauser, M. P.. (1991). Alterations of Host Defenses: The Key to the Multifaceted Spectrum of Infections in Immunocompromised Patients. Recent results in cancer research. 121. 321–328. 2 indexed citations
13.
Bille, J. & M. P. Glauser. (1991). In-vitro activity of temafloxacin for Gram-positive pathogens. Journal of Antimicrobial Chemotherapy. 28(suppl C). 9–14. 6 indexed citations
14.
Cohen, J. & M. P. Glauser. (1991). Septic shock: treatment. The Lancet. 338(8769). 736–739. 55 indexed citations
15.
Meylan, Pascal & M. P. Glauser. (1989). Role of Complement-Derived and Bacterial Formylpeptide Chemotactic Factors in the In Vivo Migration of Neutrophils in Experimental Escherichia coli Pyelonephritis in Rats. The Journal of Infectious Diseases. 159(5). 959–965. 3 indexed citations
16.
Malinverni, R & M. P. Glauser. (1988). Comparative Studies of Fluoroquinolones in the Treatment of Urinary Tract Infections. Clinical Infectious Diseases. 10(Supplement_1). S153–S163. 42 indexed citations
17.
Meylan, Pascal & M. P. Glauser. (1988). Failure of Dexamethasone to Prevent Polymorphonuclear Leukocyte Infiltration During Experimental Acute Exudative Pyelonephritis and to Reduce Subsequent Chronic Scarring. The Journal of Infectious Diseases. 157(3). 480–485. 13 indexed citations
18.
Baumgartner, J. D. & M. P. Glauser. (1987). Controversies in the Use of Passive Immunotherapy for Bacterial Infections in the Critically Ill Patient. Clinical Infectious Diseases. 9(1). 194–205. 34 indexed citations
19.
Glauser, M. P., et al.. (1981). Infection of a lumbar dermoid cyst by an anaerobic peptococcus. Acta Neurochirurgica. 58(1-2). 127–129. 9 indexed citations
20.
Glauser, M. P., et al.. (1979). Value of examining buffy coats for intragranulocytic micro-organisms in patients with fever.. BMJ. 1(6156). 85–86. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M T van den Barselaar Breakdown of academic impact, for papers by Eliza B. Wolfson Breakdown of academic impact, for papers by Fernando G. Chirdo Breakdown of academic impact, for papers by François Parant Breakdown of academic impact, for papers by Christian Draing Breakdown of academic impact, for papers by L. Amati Breakdown of academic impact, for papers by James K. Roche Breakdown of academic impact, for papers by Donald A. Ferguson Breakdown of academic impact, for papers by David P. Funda Breakdown of academic impact, for papers by Line Larivière
Rankless by CCL
2026